Centessa Pharmaceuticals plc (LON:0ACX)
London · Delayed Price · Currency is GBP · Price in USD 40.45
+0.44 (1.11%)
Inactive · Last trade price on Jun 23, 2026
Centessa Pharmaceuticals Revenue
In the year 2025, Centessa Pharmaceuticals had annual revenue of $15.00M USD.
Revenue
$15.00M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$116.28K
Employees
129
Market Cap
n/a
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 6.85M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Centessa Pharmaceuticals News
- 5 weeks ago - Global UAV Announces Proposed Acquisition of Nexus Peptide Sciences Inc. - Newsfile Corp
- 2 months ago - Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales - GlobeNewsWire
- 3 months ago - Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development - PRNewsWire
- 4 months ago - Centessa Pharmaceuticals Proxy statement: Proxy filing - Filings
- 4 months ago - Centessa Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 4 months ago - Centessa Pharmaceuticals Proxy statement: Proxy filing - Filings
- 4 months ago - Centessa Pharmaceuticals Proxy statement: Proxy filing - Filings
- 4 months ago - Centessa Pharmaceuticals Proxy statement: Proxy filing - Filings